Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Cognitive development enhancement" refers to a broad therapeutic goal of improving mental processes such as attention, learning, and memory. Strategies for cognitive enhancement act through diverse molecular targets and biological pathways, including modulation of neurotransmitter systems (dopamine, acetylcholine, glutamate), transcription factors involved in synaptic plasticity (such as CREB), structural synaptic remodeling (e.g., NMDA receptor subunits, actin cytoskeleton regulators), gene expression cascades, and metabolic modulation (such as phenylalanine metabolism in PKU)[1][2]. This concept is not a molecular target itself, but encompasses multiple possible targets and therapeutic approaches developed to address cognitive deficits in various diseases or to improve normal cognitive function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cognitive development enhancement.